Profiel
David Lambeth is the founder of Calliditas Therapeutics Suisse SA, which was founded in 2006.
He is currently a Professor at Emory University School of Medicine, where he has been working since 1980.
Dr. Lambeth received a doctorate degree from Duke University.
Actieve functies van David Lambeth
| Bedrijven | Functie | Begin |
|---|---|---|
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1980 |
Eerdere bekende functies van David Lambeth
| Bedrijven | Functie | Einde |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Oprichter | - |
Opleiding van David Lambeth
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















